Nephrolithiasis: Clinical sciences

Last updated: June 19, 2025

Nephrolithiasis: Clinical sciences

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Nephrolithiasis, also known as renal calculi or renal stones, is a painful condition where crystals form in the kidney, potentially causing urinary tract obstruction. Renal stones usually form when urine becomes oversaturated with minerals and salts, including calcium, oxalate, and uric acid. Common renal stone types include calcium oxalate-, calcium phosphate-, uric acid-, cystine-, and struvite stones.

Now, if your patient presents with a chief concern suggesting nephrolithiasis, you should first perform an ABCDE assessment to determine if your patient is unstable or stable. If unstable, stabilize the airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry. Finally, if needed, provide supplemental oxygen.

Now, here’s a clinical pearl to keep in mind! Nephrolithiasis associated with a urinary tract infection is a medical emergency that requires immediate decompression and drainage. Left untreated, it can cause complications such as pyelonephritis, renal abscess, or even sepsis. Nephrolithiasis is also an emergency when it occurs alongside renal failure, anuria, bilateral ureteral obstruction, or a single-functioning kidney. In these cases, consult the urology team immediately.

Now that we're done with unstable patients, let’s go back to the ABCDE assessment and discuss the stable ones. In these individuals, first, obtain a focused history and physical examination and order a urinalysis. Patients with nephrolithiasis typically present with an acute onset of excruciating flank pain, along with hematuria. They may also experience dysuria, nausea, or vomiting. The physical examination usually reveals unilateral flank tenderness, and urinalysis can show red blood cells, white blood cells, and crystals in the urine.

If your patient presents with these findings, you should suspect nephrolithiasis. Next, order a non-contrast helical CT scan of the abdomen and pelvis to check for stone presence. If there’s no stones on the scan, then consider alternative diagnoses. Alternatively, if the CT scan reveals a stone, that confirms the diagnosis of nephrolithiasis.

Now here’s a clinical pearl to keep in mind! When suspecting nephrolithiasis, a helical CT scan is the preferred imaging choice over both X-rays and ultrasound, because it can detect both radiolucent and radiopaque stones as small as 1 mm. Additionally, this imaging method can identify hydronephrosis. X-rays can only detect larger radiopaque stones; while ultrasound can detect hydronephrosis, but it is not reliable for identifying stones beyond the proximal ureter.

Now, once you diagnose nephrolithiasis, your next step is pain management. This can be achieved with an intravenous nonsteroidal anti-inflammatory drug, or NSAID, such as ketorolac. Avoid opioids whenever possible, as NSAIDs provide effective pain relief and have fewer adverse effects. Opioids are reserved for patients with contraindications to NSAIDs, severe kidney function impairment, or those with inadequate pain relief with NSAIDs.

After pain management, review the CT scan to assess the stone size, which will guide treatment. If the stone measures 6 millimeters or more, it's unlikely to pass on its own, so you should consult the urology team to discuss treatment options. These can include extracorporeal shock wave lithotripsy, or endoscopic removal.

On the other hand, if the stone is less than 6 millimeters, it’s possible that it might pass on its own. In this case, observe your patient for spontaneous stone passage for 4 weeks and instruct them to strain their urine using a calculi strainer, and save any stones they pass. Additionally, consider prescribing alpha-blockers, such as tamsulosin, as this can help relax the ureteral smooth muscle to facilitate stone passage.

Next, assess whether or not the stone has passed after 4 weeks. If there is no evidence of stone passage within this time frame or if the patient continues to experience symptoms, obtain a urological consult for extracorporeal shock wave lithotripsy or endoscopic removal. Also, keep in mind that patients with unpassed renal stones are at a high risk for developing hydronephrosis. So make sure you follow these patients with a renal ultrasound every 2 weeks, to ensure there’s no hydronephrosis or proximal ureteral obstruction. On the flip side, if the stone passes, no further consultations are needed.

Sources

  1. "Medical management of kidney stones: AUA guideline" J Urol (2014)
  2. "Kidney Stones: Treatment and Prevention" Am Fam Physician (2019)
  3. "Harrison’s Principles of Internal Medicine, 21st Edition" McGraw Hill Education (2022)